For a first GLP-1, the things that go wrong are usually clinical rather than financial — unscreened thyroid history, untracked metabolic markers, a dose escalated faster than tolerated. Remedy Meds is built around that risk more than most.
Semaglutide sits in a three-option range alongside tirzepatide and a twice-weekly microdose plan, available in every state plus DC. One monthly auto-payment covers medication at any prescribed dose, unlimited clinician visits, and lab work where a clinician judges it necessary.
Covering labs is the differentiator. CoreAge Rx, Mochi and Eden publish no lab requirement at all; OrderlyMeds states plainly that no bloodwork is required before prescribing. Remedy Meds orders A1C, TSH, CMP and lipids when clinically indicated and pays for them.
What you still cannot know
The monthly figure, the BMI thresholds and the medical exclusion criteria all sit behind the intake quiz. Adults 18 and over in all fifty states plus DC is the entire published eligibility statement.
That is a real cost. A provider publishing its criteria — OrderlyMeds gives BMI over 20 if you are already on a GLP-1, over 25 if you are new, with a named exclusion list — lets you self-screen for free. Remedy Meds requires you to enter the funnel to learn whether you qualify and what it costs.
Your muscle-protection numbers
Weight lost on a GLP-1 is not all fat. Protein intake and resistance training are the two levers with the best evidence behind them. Set your weight to see the targets.
Daily protein target
120–200 g
Roughly 30 g at each of four eating occasions gets you to the bottom of that range.
Resistance training
2–3 ×/week
Full-body sessions covering legs, push and pull. Loaded movement is the signal that tells your body to keep the muscle.
General nutrition and activity information, not medical advice. Protein targets can be inappropriate in kidney disease and some other conditions — check with your clinician before changing your intake.
What compounded semaglutide actually is
Semaglutide is the active ingredient in Ozempic and Wegovy, both FDA-approved products from Novo Nordisk. A compounded version is prepared by a pharmacy rather than manufactured by Novo Nordisk, and it is not an FDA-approved product. FDA has not evaluated it for safety, effectiveness or quality.
That distinction is the single most important thing to understand before buying. The efficacy data you have read about — the 15% average body-weight reduction, the cardiovascular outcomes — comes from trials of the branded product. Those results are routinely used to sell compounded versions that were never in the trials.
Dosing typically starts at 0.25 mg weekly and escalates over several months toward a maintenance dose, which is why dose-dependent pricing matters so much: a plan that looks cheap at the starting dose can cost several times more by the time you reach a therapeutic one.
The common side effects are gastrointestinal — nausea, vomiting, diarrhoea, constipation — and are usually worst in the days after a dose increase. They are the main reason people stop. Slower titration and adequate fibre and fluid intake are the standard mitigations.
Before you buy from anyone
- Get the total monthly cost in writing — medication plus any membership, not the headline figure.
- Ask whether the price changes as your dose increases. This is where most of the money is lost.
- Ask which pharmacy compounds it, and whether it is a 503A or 503B facility.
- Confirm what happens if you stop after one month, and whether there is an auto-rebill.
- Ask whether a refund is available if a provider declines to prescribe.
- Tell the prescriber every medication and supplement you take, including anything bought online.